4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-027329
EVP and Chief Medical Officer sold 5,000 shares at $109.09 ($545,450)
- EVP and Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-15 | Exercise or conversion : show line 1 in the form | +5,000 | $55.00 | $275,000 | 44,139 | D |
| 2021-04-15 | Sale : show line 2 in the form | −5,000 | $109.09 | $545,450 | 39,139 | D |
| Open-market sales · 5,000 sh · avg $109.09 · $545,450 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-15 | Exercise or conversion : show line 3 in the form Stock Option | −5,000 | 58,000 | D |
Loading xslF345X03/doc4.xml…